🌐 WorldLive
Accueil🇦🇺 AustralieSanté

New GLP-1 Clinical Study Finds Calocurb® Reduces Body Weight and Body Fat Without Loss of Muscle Mass

The natural GLP-1 activator is clinically shown to support fat loss, including visceral fat reduction, while preserving lean muscle AUCKLAND, New Zealand–BUSINESS WIRE– Calocurb, the New Zealand-based company bringing the world the first 100% natural GLP-1 activator, announces today the publication of a new clinical study in US medical journal, Obesity Pillars, demonstrating Calocurb’s effectiveness ... Continued